The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Mechanism of Action of Anti-Inflammatory Drugs
Abstract
Cyclooxygenase (COX) is the pivotal enzyme in prostaglandin biosynthesis. It exists in two isoforms, constitutive COX-1 (responsible for physiological functions) and inducible COX-2 (involved in inflammation). Inhibition of COX explains both the therapeutic effects (inhibition of COX-2) and side effects (inhibition of COX-1) of non-steroidal anti-inflammatory drugs (NSAIDs). A NSAID which selectively inhibits COX-2 is likely to retain maximal anti-inflammatory efficacy combined with less toxicity. The activity of a number of NSAIDs has been investigated in several test systems, showing that most of those marketed have higher activities against COX-1 or are equipotent against both isoforms. Adverse event data of marketed NSAIDs show a relationship between a poor safety profile and more potent inhibition of COX-1 relative to COX-2. There are several new non-steroidal COX-2 inhibitors in development. The most clinically advanced is meloxicam, which consistently demonstrates higher activity against COX-2 than COX-1 in several test systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Self-citationMoncada, S., Gryglewski, R., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,595
Self-citationAltman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98774-0 · Cited by 1,789
Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2692 · Cited by 1,707
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659
Self-citationSeibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets
SMITH, J. B., & WILLIS, A. L. (1971) · Nature New Biology · doi:10.1038/newbio231235a0 · Cited by 1,521
Drugs Which Inhibit Prostaglandin Biosynthesis
Flower, R. J. (1974) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06634-7 · Cited by 1,323
The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
Picot, D., Loll, P. J., & Garavito, R. M. (1994) · Nature · doi:10.1038/367243a0 · Cited by 1,265
Meade, E. A., Smith, W. L., & DeWitt, D. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53294-4 · Cited by 1,256
Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082
Acetylation of prostaglandin synthase by aspirin.
Roth, G. J., Stanford, N., & Majerus, P. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.3073 · Cited by 1,009
Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
Murphy, R. C., Hammarström, S., & Samuelsson, B. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4275 · Cited by 991
García Rodríguez, L., & Jick, H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91843-0 · Cited by 975
The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.
Fu, J. Y., Masferrer, J. L., Seibert, K., Raz, A., & Needleman, P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44821-6 · Cited by 944
Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231237a0 · Cited by 941
Self-citationRisks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
Langman, M. J. S., Weil, J., Wainwright, P., Lawson, D. H., Rawlins, M. D., Logan, R. F. A., Murphy, M., Vessey, M. P., & Colin-Jones, D. G. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90185-6 · Cited by 872
Prostaglandins, Aspirin-like Drugs and Analgesia
FERREIRA, S. H. (1972) · Nature New Biology · doi:10.1038/newbio240200a0 · Cited by 866
Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., Dubois, R. N., & Breyer, M. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117620 · Cited by 860
New insights into the mode of action of anti-inflammatory drugs
Vane, J. R., & Botting, R. M. (1995) · Inflammation Research · doi:10.1007/bf01630479 · Cited by 838
Self-citationHenry, D., Lim, L. L.-Y., Rodriguez, L. A. G., Gutthann, S. P., Carson, J. L., Griffin, M., Savage, R., Logan, R., Moride, Y., Hawkey, C., et al. (1996) · BMJ · doi:10.1136/bmj.312.7046.1563 · Cited by 827
Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., & Otomo, S. (1994) · Prostaglandins · doi:10.1016/0090-6980(94)90074-4 · Cited by 826
cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.
O'Banion, M. K., Winn, V. D., & Young, D. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4888 · Cited by 821
Lee, S. H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D., & Hwang, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35698-9 · Cited by 811
FLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779
Self-citationAnti-inflammatory actions of steroids: molecular mechanisms
Barnes, P. J., Adcock, I., Spedding, M., & Vanhoutte, P. M. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90184-l · Cited by 725
Wallner, B. P., Mattaliano, R. J., Hession, C., Cate, R. L., Tizard, R., Sinclair, L. K., Foeller, C., Chow, E. P., Browning, J. L., Ramachandran, K. L., et al. (1986) · Nature · doi:10.1038/320077a0 · Cited by 664
Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes.
Miyamoto, T., Ogino, N., Yamamoto, S., & Hayaishi, O. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33534-2 · Cited by 663
Prostaglandin endoperoxide synthase: regulation of enzyme expression
DeWitt, D. L. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90032-d · Cited by 637
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2
Luong, C., Miller, A., Barnett, J., Chow, J., Ramesha, C., & Browner, M. F. (1996) · Nature Structural Biology · doi:10.1038/nsb1196-927 · Cited by 618
Miller, T. A. (1983) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1983.245.5.g601 · Cited by 589
Funk, C. D., Funk, L. B., Kennedy, M. E., Pong, A. S., & Fitzgerald, G. A. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.9.1907252 · Cited by 571
A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein.
O'Banion, M. K., Sadowski, H. B., Winn, V., & Young, D. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54491-4 · Cited by 557
Patrignani, P., Panara, M. R., Greco, A., Fusco, O., Natoli, C., Iacobelli, S., Cipollone, F., Ganci, A., Créminon, C., & Maclouf, J. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24061-7 · Cited by 518
Role of prostaglandin-mediated vasodilatation in inflammation
WILLIAMS, T. J., & PECK, M. J. (1977) · Nature · doi:10.1038/270530a0 · Cited by 515
Laneuville, O., Breuer, D. K., Dewitt, D. L., Hla, T., Funk, C. D., & Smith, W. L. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23861-7 · Cited by 472
Kargman, S., Charleson, S., Cartwright, M., Frank, J., Riendeau, D., Mancini, J., Evans, J., & O'Neill, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8690211 · Cited by 462
Kutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., & Prescott, S. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4816 · Cited by 449
Hemler, M., & Lands, W. E. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33098-3 · Cited by 437
Gierse, J. K., McDonald, J. J., Hauser, S. D., Rangwala, S. H., Koboldt, C. M., & Seibert, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15810 · Cited by 410
Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.
Copeland, R. A., Williams, J. M., Giannaras, J., Nurnberg, S., Covington, M., Pinto, D., Pick, S., & Trzaskos, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11202 · Cited by 408
Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene.
Kujubu, D. A., & Herschman, H. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42398-8 · Cited by 402
Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice.
Masferrer, J. L., Zweifel, B. S., Seibert, K., & Needleman, P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114850 · Cited by 402
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
Whittle, B. J. R., Higgs, G. A., Eakins, K. E., Moncada, S., & Vane, J. R. (1980) · Nature · doi:10.1038/284271a0 · Cited by 392
Self-citationLipocortin-1: cellular mechanisms and clinical relevance
Flower, R. J., & Rothwell, N. J. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90281-x · Cited by 375
Engelhardt, G., Homma, D., Schlegel, K., Utzmann, R., & Schnitzler, C. (1995) · Inflammation Research · doi:10.1007/bf01757699 · Cited by 333
Chan, C. C., Boyce, S., Brideau, C., Ford-Hutchinson, A. W., Gordon, R., Guay, D., Hill, R. G., Li, C. S., Mancini, J., & Penneton, M. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10713-1 · Cited by 313
Sirois, J., & Richards, J. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42706-8 · Cited by 306
Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs
Xie, W., Robertson, D. L., & Simmons, D. L. (1992) · Drug Development Research · doi:10.1002/ddr.430250402 · Cited by 306
Prostaglandin Synthetase Inhibitors I
Shen, T. Y. (1979) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-66891-3_12 · Cited by 274
Gans, K. R., Galbraith, W., Roman, R. J., Haber, S. B., Kerr, J. S., Schmidt, W. K., Smith, C., Hewes, W. E., & Ackerman, N. R. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12610-4 · Cited by 231
Raz, A., Wyche, A., & Needleman, P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.5.1657 · Cited by 227
The National Research Centre for Disaster Prevention
SUGAWARA, M. (1972) · Nature · doi:10.1038/240200a0 · Cited by 226
Higgs, G. A., Salmon, J. A., Henderson, B., & Vane, J. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1417 · Cited by 222
Self-citationSolomon, L. M., Kirschenbaum, M. B., & Juhlin, L. (1968) · Journal of Investigative Dermatology · doi:10.1038/jid.1968.128 · Cited by 193
O'Neill, G. P., Mancini, J. A., Kargman, S., Yergey, J., Kwan, M. Y., Falgueyret, J. P., Abramovitz, M., Kennedy, B. P., Ouellet, M., & Cromlish, W. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09920-1 · Cited by 181
Selective inhibition of cyclooxygenase 2
Klein, T., Nüsing, R. M., Pfeilschifter, J., & Ullrich, V. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90205-4 · Cited by 180
History of aspirin and its mechanism of action.
Vane, J. R., Flower, R. J., & Botting, R. M. (1990) · PubMed · Cited by 170
Self-citationAcetylation of Prostaglandin Endoperoxide Synthetase with Acetylsalicylic Acid
OUDERAA, F. J., BUYTENHEK, M., NUGTEREN, D. H., & VAN DORP, D. A. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb04760.x · Cited by 160
Futaki, N., Arai, I., Hamasaka, Y., Takahashi, S., Higuchi, S., & Otomo, S. (1993) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1993.tb07103.x · Cited by 154
Wu, K. K., Sanduja, R., Tsai, A., Ferhanoğlu, B., & Loose, D. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2384 · Cited by 146
Wu, C. C., Croxtall, J. D., Perretti, M., Bryant, C. E., Thiemermann, C., Flower, R. J., & Vane, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3473 · Cited by 142
Self-citationGrossman, C. J., Wiseman, J. O., Lucas, F. S., Trevethick, M. A., & Birch, P. J. (1995) · Inflammation Research · doi:10.1007/bf01782978 · Cited by 126
Kulmacz, R. J., Pendleton, R. B., & Lands, W. E. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37493-8 · Cited by 120
Gustafson‐Svärd, C., Lilja, I., Hallböök, O. J., & Sjödahl, R. I. (1996) · Gut · doi:10.1136/gut.38.1.79 · Cited by 113
NSAIDs: time to re-evaluate gut toxicity
Bateman, D. N. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90175-9 · Cited by 97
Selective inhibition of human cyclo-oxygenase-2 by meloxicam
Churchill, L., Graham, A. G., Shih, C.-K., Pauletti, D., Farina, P. R., & Grob, P. M. (1996) · Inflammopharmacology · doi:10.1007/bf02735467 · Cited by 93
NSAIDs, Cox-2 inhibitors, and the gut
Hayllar, J. S., & Bjarnason, I. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91962-7 · Cited by 87
(1992) · PubMed · Cited by 85
Regulation of mesangial cell cyclooxygenase synthesis by cytokines and glucocorticoids
Coyne, D. W., Nickols, M., Bertrand, W. S., & Morrison, A. R. (1992) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1992.263.1.f97 · Cited by 83
Preston, S., Arnold, M. H., Beller, E., Brooks, P., & Buchanan, W. W. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03423.x · Cited by 74
Boyce, S. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90137-6 · Cited by 69
Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery
Cirino, G., & Flower, R. J. (1987) · Prostaglandins · doi:10.1016/0090-6980(87)90262-0 · Cited by 67
NSAIDs, Cox-2 inhibitors, and the gut
Hayllar, J. S., & Bjarnason, I. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91378-5 · Cited by 61
Review of Clinical Trials and Benefit/Risk Ratio of Meloxicam
Barner, A. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609097228 · Cited by 55
NSAIDs, Cox-2 inhibitors, and the gut
Bennett, A. B., Tavares, I. A., & Vane, J. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91782-9 · Cited by 49
Self-citationAntiarthritic profile of BF-389 — A novel anti-inflammatory agent with low ulcerogenic liability
Wong, S., Lee, S. J., Frierson, M. R., Proch, J., Miskowski, T. A., Rigby, B. S., Schmolka, S. J., Naismith, R. W., Kreutzer, D. C., & Lindquist, R. R. (1992) · Inflammation Research · doi:10.1007/bf01987895 · Cited by 29
Discovery of a better aspirin.
Isakson, P. C., Seibert, K., Masferrer, J. L., Salvemini, D., Lee, L., & Needleman, P. (1995) · PubMed · Cited by 28
Cited by
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
Wolfe, M. M., Lichtenstein, D. R., & Singh, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402407 · Cited by 1,956
NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2
Wallace, J. L., McKnight, W., Reuter, B. K., & Vergnolle, N. (2000) · Gastroenterology · doi:10.1053/gast.2000.16510 · Cited by 705
Banks, W. A., Gray, A. M., Erickson, M. A., Salameh, T. S., Damodarasamy, M., Sheibani, N., Meabon, J. S., Wing, E. E., Morofuji, Y., Cook, D. G., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0434-1 · Cited by 636
Diclofenac: an update on its mechanism of action and safety profile
Gan, T. J. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.486301 · Cited by 600
Metadata
- Authors
- Vane, J. R., & Botting, R. M.
- Venue
- Scandinavian Journal of Rheumatology
- Publisher
- Informa UK Limited
- Published
- 1996-01
- Volume
- 25
- Issue
- sup102
- Pages
- 9-21
- ISSN
- 0300-9742 (ISSN-L)
- 1502-7732
- OpenAlex
- W2017917394
- Cited by
- 465
- References
- 83
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.